Amphastar Pharmaceuticals, Inc. (AMPH) Company Cash Funds

Amphastar Pharmaceuticals (AMPH) cash reserves reflect the impact of demand for inhalers and generic injectables, where the value of 0.23 expresses the state of the metric. Growth is supported by the automation of sterile zones and AI-driven dosage control. However, patent disputes and pressure from industry behemoths create risks. This chart allows for the separation of speculative noise from the issuer's actual financial stability.
Financial and market metric breakdowns for Amphastar (AMPH)

Total liquid reserves determine the issuer's financial stability, capturing its ability to withstand crises and avoid defaults. The free cash flow dynamics on GURU.Markets allow for the prompt identification of cash flow gaps, which is critical for Amphastar Pharmaceuticals (AMPH), whose high margins in the complex injectable generics segment ensure a steady inflow of funds and a strategic capital reserve.